pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2d ago·3 min read
save

STAT+: What the midterms could mean for the future of health AI

The midterms highlighted the negative sentiment around AI across the U.S. How will those attitudes trickle down to legislating AI use in health care?

Nov 5, 2026·read at STAT ↗

STAT PlusHealth tech What the midterms could mean for the future of health AI How the election could impact AI sandboxes and legislation on the FDA Manage alerts for this article Save this story for later Share this article By Mario AguilarNov. 5, 2026 Health Tech Correspondent Mario Aguilar[email protected]Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter.

You can reach Mario on Signal at mariojoze.13. Tuesday’s midterm elections highlighted the negative sentiment around artificial intelligence across the country, with voters roundly rejecting the data centers required to power the technology on dozens of ballot measures across several states. The results echo polling that shows many Americans believe AI does more harm than good.

An open question is how these attitudes might trickle down to legislation and policy around AI use in health care. Important issues on deck for lawmakers next year include state bills that introduce “sandboxes” to test AI products, and national legislation that might clarify the Food and Drug Administration’s authorities as well as reimbursement for AI. Advertisement AI has emerged as a “boogeyman” that inspires fear, and data centers as a symbol of what’s viewed as the Trump administration’s excessive coziness with the technology industry, said Eric Fish, a partner at law firm Hooper Lundy & Bookman, who formerly served as chief legal officer for the Federation of State Medical Boards.

STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. Already have an account?

Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+.

Subscribe Log In Artificial intelligence, Congress, FDA, health tech, Policy, STAT+ Submit a correction requestReprints Mario Aguilar Health Tech Correspondent Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

Newsletter Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve. Recommended Health tech November 5, 2026 STAT Plus: As more doctors consult chatbots, health systems can block them — or buy in Biotech November 5, 2026 STAT Plus: In China, a flood of controversial clinical trials slows to a trickle Advertisement First Opinion November 5, 2026 I’m a neurosurgeon.

I’ve learned pain and suffering are very different things Politics November 4, 2026 STAT Plus: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill Politics November 4, 2026 STAT Plus: Mass. marijuana consumers, workers high on victory after repeal of recreational weed sales fails in a rout Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
577 words · retrieved 2d ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Psychiatry & CNS2Pain

related stories

  • Sep 21Addiction clinics see rising cases of kratom and 7-OH withdrawalSTAT
  • Sep 15STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseasesSTAT
  • Sep 3Psilocybin proves promising in neuropathic pain mouse studyFierce Biotech
  • Aug 27Opinion: I studied Reddit forums on menopause — and found what doctors are missingSTAT
  • Aug 19Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: AnalystsBioSpace